Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Establishing post mortem criteria for the metabolic syndrome: an autopsy based cross-sectional study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Supportive and non-supportive interactions in families with a type 2 diabetes patient: an integrative review

    Research output: Contribution to journalReviewResearchpeer-review

  1. Plasma GDF15 levels are similar between subjects after bariatric surgery and matched controls and are unaffected by meals

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Dulaglutide for erectile dysfunction in type 2 diabetes

    Research output: Contribution to journalComment/debateResearchpeer-review

  3. The antiresorptive effect of GIP, but not GLP-2, is preserved in patients with hypoparathyroidism- a randomized crossover study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Obesity is characterized by low grade inflammation and an altered secretion of inflammatory cytokines from the adipose tissue. Weight loss has shown to reduce inflammation; however, changes in cytokine profiles during massive weight loss are not well described. The present study explored the hypothesis that Roux-en-Y gastric bypass (RYGB) reduces circulating levels of pro-inflammatory cytokines, while increasing anti-inflammatory cytokines in obese subjects with type 2 diabetes (T2D) and in obese normal glucose tolerant (NGT) subjects.

METHODS: Thirteen obese subjects with T2D [weight; 129 ± 14 kg, glycated hemoglobin (HbA1c); 7.0 ± 0.9%, body mass index (BMI); 43.2 ± 5.3 kg/m(2), mean ± SD] and twelve matched obese NGT subjects [weight; 127 ± 15 kg, HbA1c; 5.5 ± 0.4%, BMI; 41.5 ± 4.8 kg/m(2), mean ± SD] were examined before, one week, three months, and one year after surgery. Interleukin (IL)-6, leptin, adiponectin, IL-8, transforming growth factor beta (TGF-β), and the incretin hormone glucagon-like peptide-1 (GLP-1) were measured in the fasting state and during a liquid meal. Insulin resistance was evaluated by HOMA-IR.

RESULTS: Weight loss did not differ between the two groups. Before surgery, HbA1c was higher and HOMA-IR lower in T2D patients, however, converged to the values of NGT subjects one year after surgery. Circulating cytokine concentrations did not differ between the two groups at any time point. One week after surgery, circulating IL-6 and IL-8 were increased, while adiponectin and leptin were reduced compared with pre-surgical concentrations. Three months after surgery, IL-8 was increased, leptin was reduced, and no change was observed for IL-6, TGF-β, and adiponectin. One year after surgery, concentrations of IL-6, TGF-β, and leptin were significantly reduced compared to before surgery, while adiponectin was significantly increased.

CONCLUSIONS: One year after RYGB, fasting concentrations of IL-6 and leptin were reduced, while no changes were observed in IL-8. TGF-β was decreased and adiponectin increased in both T2D and NGT obese subjects. This study is the first to examine IL-8 and TGF-β in obese subject after RYGB. Resolution of inflammation could offer a potential explanation for the health improvement associated with major weight loss after bariatric surgery.


Original languageEnglish
JournalDiabetology & Metabolic Syndrome
Issue number12
Pages (from-to)12
Publication statusPublished - 2015

ID: 46032005